Shu‐Feng Zhou

Research interests

Publications

• Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

  Nature Genetics · 2023 · https://doi.org/10.1038/s41588-023-01422-x

• Exploring the Role of Autophagy-Related Gene 5 (ATG5) Yields Important Insights Into Autophagy in Autoimmune/Autoinflammatory Diseases

  Frontiers in Immunology · 2018 · 10.3389/fimmu.2018.02334

• Electrochemical hydrogen sulfide biosensors

  The Analyst · 2016 · 10.1039/c5an02208h

• High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry

  Nature Genetics · 2016 · 10.1038/ng.3496

• Molecular mechanisms for tumour resistance to chemotherapy

  Clinical and Experimental Pharmacology and Physiology · 2016 · 10.1111/1440-1681.12581

• Cancer stem cell targeted therapy: progress amid controversies

  Oncotarget · 2015 · 10.18632/oncotarget.6176

• RNA aptamers targeting cancer stem cell marker CD133

  Cancer Letters · 2012 · 10.1016/j.canlet.2012.11.032

• Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population

  Annals of the Rheumatic Diseases · 2011 · 10.1136/ard.2010.140111

• New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme

  Drug Metabolism Reviews · 2009 · 10.1080/03602530903118729

• Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

  Clinical Pharmacokinetics · 2009 · 10.2165/11318070-000000000-00000

• Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

  Current Drug Metabolism · 2008 · https://doi.org/10.2174/138920008784220664

• Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development

  Current Medicinal Chemistry · 2008 · 10.2174/092986708785132870

• Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring

  Therapeutic Drug Monitoring · 2007 · 10.1097/ftd.0b013e31815c16f5

• Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

  Drug Metabolism Reviews · 2005 · 10.1081/dmr-200028812

• Herb-Drug Interactions

  Drugs · 2005 · 10.2165/00003495-200565090-00005

• Metabolism and Transport of Oxazaphosphorines and the Clinical Implications

  Drug Metabolism Reviews · 2005 · 10.1080/03602530500364023

• Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

  Clinical Pharmacokinetics · 2005 · 10.2165/00003088-200544030-00005

• Pharmacokinetic Interactions of Drugs with St John’s Wort

  Journal of Psychopharmacology · 2004 · 10.1177/0269881104042632

• Herbal Modulation of P‐Glycoprotein

  Drug Metabolism Reviews · 2004 · 10.1081/dmr-120028427

• Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4

  Current Drug Metabolism · 2004 · 10.2174/1389200043335450

• Herbal bioactivation: The good, the bad and the ugly

  Life Sciences · 2003 · 10.1016/j.lfs.2003.09.035

• Interactions of Herbs with Cytochrome P450

  Drug Metabolism Reviews · 2003 · 10.1081/dmr-120018248

Current projects

No projects listed.